• BX Home
  • Multiple Sclerosis: News [Page 22]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

MULTIPLE SCLEROSIS

Multiple sclerosis (MS) is an autoimmune condition that attacks the central nervous system. This topic tracks information on multiple sclerosis treatments and the financial impact on companies researching and developing new drugs to fight this terrible disease.

Multiple Sclerosis is part of Business Exchange, suggested by Steve McCarthy. This topic contains 967 news and 242 blog items. Read updated news, blogs, and resources about Multiple Sclerosis. Find user-submitted articles and reactions on Multiple Sclerosis from like-minded professionals.

News

Please add new articles to this topic

Wheelchair team's Snowdon successmore

and his support team have been training for months for the Snowdon ascent A former hill walker with multiple sclerosis...

Rights violatedmore

the ADA. I am 58 years old and was reminded of the problems I faced at 40 when multiple sclerosis forced me into...

Jolly, Frankmore

Resident Frank Taylor Jolly Sr., 72, passed away July 23 surrounded by friends and family. He courageously battled...

Elan puts sale of drug delivery unit on holdmore

in 2008, but failed after the economic crisis led to a financing drought. The company, which makes the multiple...

Inspired by Flying, and Inspiring Othersmore

engineer for the Boeing Defense, Space and Security Phantom Works group. He is also a pilot, undeterred by multiple...

Better treatment urged for Iranian prisoners on hunger strikemore

Melli party. Families have said several of the prisoners are suffering health problems; some require care for diabetes,...

Recession-battered states cut funding for the disabledmore

use her arms and hands. She and her husband, Mike Irvin, 53, who uses a wheelchair because of multiple sclerosis, live...

Chazzano Coffee brews up growing customer base; Henry Ford Health Syst...more

~ Detroit���s Better Made Snack Foods and Roseville���s National Coney Island are teaming up to fight multiple...

Novel multiple sclerosis theory dealt a blow by studiesmore

A novel theory about the cause of multiple sclerosis ? one that quickly led to millions of dollars in research pledges...

A.M. Vitals: Humana Profit Up 21% On New Enrollmentmore

Theory Questioned: Two studies published today in the Annals of Neurology find no evidence for the hypothesis that...

Landmark embryonic stem cell study to proceedmore

preclinical animal study. If successful, Geron's therapy, called GRNOPC1, may also have applications for Alzheimer's...

Geron Gets Cleared for First Embryonic Stem-Cell Testmore

the shoulders, Okarma said. Geron also wants to conduct future trials in patients with other neurological conditions...

Bayer's 2nd-quarter profit down 1.3 percentmore

by lower demand in the U.S., where there was increasing competition from generic drugs; and sales of multiple sclerosis...

FDA grants priority review to EMD Serono drugmore

Administration has granted the company a priority review for Cladribine Tablets as a therapy for relapsing forms of...

3 Firms With Surprising Sales and Earnings (Screens)more

Wall Street forecasters. The drug developer is solidly profitable. Its major money makers include Avonex and Tysabri...

Branded? Generic? They're Both Doing Great!more

in Teva Pharmaceutical's (Nasdaq: TEVA) That's not to say the 21% increase in sales of its multiple sclerosis drug...

Novartis Exec: Golden Age Of Generic Biotech Drugs Is Comingmore

significant role." The two companies also have a partnership on making a generic version of Teva's multiple...

Sniff-and-Go Technology Enables Paralyzed to Drive Wheelchairsmore

nonprofit research and advocacy organization. Stroke is the leading cause of paralysis, followed by spinal cord injury...

India's Apollo tackles MS frontiersmore

Extract not available.

Teva Pharma Drops On Worries Of Generic Copaxone Threatmore

of a generic version of Sanofi-Aventis SA's (SAN.FR, SNY) blood thinner Lovenox signals that Teva's multiple sclerosis...

Elan���s Loss Widens After Cash Set Aside for Zonegranmore

million as falling demand for older drugs wasn���t enough to offset a surge in sales of the multiple sclerosis medicine...

Biogen Looks Good Now, but What About Tomorrow?more

Biogen Idec (Nasdaq: BIIB) Sales of Tysabri, the multiple sclerosis drug it sells with Elan (NYSE: ELN) Biogen's two...

Activist Investor Seeks to Shake Up Elanmore

Zoar Invest, controls about two million Elan shares, or about a 0.3% stake. Elan, which markets the multiple sclerosis...

Rel Life Sciences to focus on R&D, for nowmore

molecule will be part of the biosimilar portfolio. Biosimilar of interferon beta, used to treat nervous system...

Biogen Idec and Swedish Orphan Biovitrum Present Data on Long-Lasting ...more

of innovative therapies. Patients worldwide benefit from Biogen Idec's significant products that address diseases such...

Top Sources: Multiple Sclerosis

  • St. Petersburg Times
  • Reuters
  • Chicago Tribune
  • MarketWatch
  • Mail Online UK
  • BBC
  • Boston Globe
  • Philadelphia Inquirer
  • BusinessWeek
  • Wall Street Journal Online

Most Active Users in this Topic

see all contributors in Multiple Sclerosis

Featured White Papers

Post a Job

Jobs in this Topic

RN/Registered Nurse Clinical Coordinator - Ambulatory Mulitple Sclerosis Center Rush University Medical Center | Chicago, IL
Posted: May 14
Multiple Sclerosis Nurse Educator Quintiles Transnational | Hartford, CT
Posted: Jun 10
Associate Director Marketing - Multiple Sclerosis San Francisco, CA
Posted: Jun 13
Product Manager - Multiple Sclerosis A Pharmaceutical / Biotech Company | San Francisco, CA
Posted: Jun 13
Patient Service Rep - Multiple Sclerosis/Mellen Dept, CCHS Employees Only Job Cleveland Clinic Foundation | Cleveland, OH
Posted: Jun 10

Report comment contains invalid characters. ()
cancel
Search Cancel